Highlights

  • Zycov D likely to be available from October
  • Deemed safe for children above 12 years of age
  • 3 doses with 28 day intervals recommended

Latest news

Dominique Pelicot sentenced to 20 years in landmark French mass rape case

Dominique Pelicot sentenced to 20 years in landmark French mass rape case

PM Modi speaks to King Charles, reaffirms India-UK strategic partnership

PM Modi speaks to King Charles, reaffirms India-UK strategic partnership

Omar Abdullah meets Amit Shah, discusses J&K's statehood restoration

Omar Abdullah meets Amit Shah, discusses J&K's statehood restoration

Unprecedented fracas on Parliament premises, 2 BJP MPs injured; NDA, Congress file police complaints

Unprecedented fracas on Parliament premises, 2 BJP MPs injured; NDA, Congress file police complaints

Palestinians say six killed in Israeli West Bank operations

Palestinians say six killed in Israeli West Bank operations

Around 70 Hindu pilgrims arrive in Pak from India to perform religious rituals at Katas Raj temples

Around 70 Hindu pilgrims arrive in Pak from India to perform religious rituals at Katas Raj temples

Delhi Elections: MCD passes proposal to release Rs 25.35 crore for preparations

Delhi Elections: MCD passes proposal to release Rs 25.35 crore for preparations

Global stocks struggle amid inflation, economic fears: December 19, 2024 analysis

Global stocks struggle amid inflation, economic fears: December 19, 2024 analysis

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

The shot is “the world’s first and India’s indigenously developed DNA-based vaccine for Covid-19 to be administered in humans including children and adults 12 years and above.”

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

Zydus Cadila's covid vaccine ZyCoV-D is set to be launched in India in October and is deemed for safe for kids above 12. This 'third-generation triple dose vaccine' could just be the answer to fill the gap of 100 crore doses required by year-end to vaccinate the vast majority of the adult population. Here is everything you need to know about this non-injecting, DNA vaccine which even children above 12 can take.

Meet Cadila’s ZyCoV-D

  • It is the world’s first DNA vaccine to protect against Covid 19. Requires a triple dose for immunity and showcased 67% efficacy in trials. The vaccine is deemed safe for children above the age of 12.

What kind of vaccine is it? How is it different than Covishield and Covaxin?

  • Cadila’s ZyCoV-D is a plasmid DNA vaccine that introduces a DNA sequence encoding the antigen in the body and not a weakened form of the pathogen like Covaxin.

How does a DNA vaccine work?

  • Often referred to as the third-generation vaccines, the dose carries the genetic code of the virus that triggers the build up of immunity in one's body.
  • Zydus stated that the plasmid DNA platform is “ideally suited for dealing with Covid-19 as it can be easily adapted to deal with mutations in the virus, such as those already occurring”.

Is a DNA vaccine being used anywhere else in the world?

  • No DNA vaccine has been widely used against any disease so far, but they are more stable and easier to store than mRNA shots (tech used by Pfizer & Moderna)
  • According to the U.S. National Library of Medicine, over 160 different DNA vaccines are currently being tested in human clinical trials in the United States. It is estimated that 62% of these trials are devoted to cancer vaccines and 33% are applied for vaccines against human immunodeficiency virus (HIV).

How many doses does one need?

  • Unlike most other Covid-19 vaccines, which require two doses for full immunity, ZyCoV-D is administered in three doses. The vaccine is also needle-free.
  • The doses will be administered 28 days apart

Needle-free vaccine, how does one get the dose?

  • Doses are given using a device that delivers fluid through a spring-powered jet that penetrates the skin, developed by Pharmajet’s Tropis.
  • Zydus Cadila claims this method of delivery is painless and could also reduce side effects from the jab

Is it safe? What are the trial results showing?

  • The vaccine has been tested on almost 30,000 participants across Phase I, II and III studies, and is the first vaccine in India to be tested on 12 to 18-year-olds. Around 1,000 participants were enrolled in the adolescent age group, among whom the vaccine was found to be safe and well-tolerated, with similar findings in the adult population

ADVERTISEMENT

Up Next

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

Meet ZyCoV-D: The world’s first DNA Covid-19 vaccine; everything you need to know about the new vaccine

India's electric vehicle market to reach Rs 20 lakh crore by 2030, says Nitin Gadkari

India's electric vehicle market to reach Rs 20 lakh crore by 2030, says Nitin Gadkari

Mallya Calls for Justice Over Excess Debt Recovery and Legal Inconsistencies

Mallya Calls for Justice Over Excess Debt Recovery and Legal Inconsistencies

UK PM Keir Starmer hosts Indian business chiefs to boost investments

UK PM Keir Starmer hosts Indian business chiefs to boost investments

Bangladesh Government Plans to Renegotiate Power Deal with Adani Power, Citing Unfair Terms

Bangladesh Government Plans to Renegotiate Power Deal with Adani Power, Citing Unfair Terms

New Zealand falls into recession with abrupt economic slowdown

New Zealand falls into recession with abrupt economic slowdown

ADVERTISEMENT

editorji-whatsApp

More videos

Dollar Pushes Indian Rupee to Record Low of 85, Fed's Policy Outlook in Focus

Dollar Pushes Indian Rupee to Record Low of 85, Fed's Policy Outlook in Focus

Oil Prices Rally on Inventory Drop, Market Awaits Fed Projections

Oil Prices Rally on Inventory Drop, Market Awaits Fed Projections

SEBI Expands UPSI Definition, Strengthens ESG and Governance Frameworks

SEBI Expands UPSI Definition, Strengthens ESG and Governance Frameworks

Gold Imports surge in November: Commerce Ministry examining data for any calculation error

Gold Imports surge in November: Commerce Ministry examining data for any calculation error

Indian Stock Market: Mixed Sectoral Performance Amid IPO Highlights

Indian Stock Market: Mixed Sectoral Performance Amid IPO Highlights

Parliamentary Panel bats for legal guarantee of MSP to protect farmers' interests

Parliamentary Panel bats for legal guarantee of MSP to protect farmers' interests

Bihar fully prepared to create robust business ecosystem, investment safe: Dy CM Samrat Choudhary

Bihar fully prepared to create robust business ecosystem, investment safe: Dy CM Samrat Choudhary

"If they tax us, we tax them...," Trump Signals Tough Trade Stance; Reciprocal Tariffs on India

"If they tax us, we tax them...," Trump Signals Tough Trade Stance; Reciprocal Tariffs on India

Top 5 Losers of NIFTY 50: A Day of Decline for Leading Stocks

Top 5 Losers of NIFTY 50: A Day of Decline for Leading Stocks

India's renewable energy capacity addition doubled to 15 GW in Apr-Nov: Pralhad Joshi

India's renewable energy capacity addition doubled to 15 GW in Apr-Nov: Pralhad Joshi

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.